You must read and accept the disclaimer to use this site. Updated for monthly, 2011

Use of vitamin C to control cancer

For people dealing with cancer, I have recently reviewed some key articles about the use of vitamin C (ascorbic acid, AA) to treat cancer. I am fortunate to be able to consult with two of the top experts about the use of AA for treating cancer. AA can be taken orally, but is most effective when given intravenously. In the classic paper by Linus Pauling, 2. below, people diagnosed with terminal cancer took 10 g AA daily. Note that in vitro 1mM AA kills human cancer cells without harming normal cells, and 14mM AA has been used in vivo through IV adminstration to human patients with advance cancer.

Assuming that taking vitamin C supplements above 500 mg twice a day are quickly filtered by the kidneys into the urine, and that typical urine output is no more than 2 liters per day, then taking 3 g of vitamin C twice a day would provide at least 14mM AA in the bladder continuously, which might be toxic to bladder cancer cells in the innermost layer of the bladder.

Below are some key references related to using high oral and intravenous levels of vitamin C to destroy cancer cells in human beings. Many people dealing with cancer would be well advised to examine these articles and discuss the use of vitamin C to help control cancer.

1. 2011 - Review Phys Pharm Adv Nutr 2011 Levine.pdf, Vitamin C: A Concentration-Function Approach Yields Pharmacology andTherapeutic Discoveries, Mark Levine,* et al, Adv. Nutr. 2: 78–88, 2011."With ingested amounts found in foods, vitamin C plasma concentrations do not exceed 100 mmol/L. Even with supplementation approaching maximally tolerated doses, ascorbate plasma
concentrations are always <250 mmol/L and frequently <150 mmol/L. By contrast, when ascorbate is i.v. injected, tight control is bypassed until excess ascorbate is eliminated by glomerular filtration and renal excretion. With i.v. infusion, pharmacologic ascorbate concentrations of 25–30
mmol/L are safely achieved." SUMMARY: 25mM/L in serum is safe.

2. 1978 - pnas00668-0476.pdf, Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer* (vitamin C) EWAN CAMERONt AND LINUS PAULING, Proc. Nati. Acad. Sci. USA Vol. 75, No. 9, pp. 4538-4542, September 1978 SUMMARY: 10g/d orally; LINUS PAULING's work; includes 7 case-control bladder cancer patients taking 10g/day vitamin C; prolonged survival; no side effects.

3. 2010 - CAM Pharm Ascorbate 2010 PLoS One Padayatty.pdf; Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects Sebastian J. Padayatty PLoS ONE 5(7): e11414. doi:10.1371/journal.pone.0011414 SUMMARY: Conclusions: High dose IV vitamin C is in unexpectedly wide use by Complementary and Alternate Medicine practitioners. 172 practitioners administered IV vitamin C to 11,233 patients in 2006 and 8876 patients in 2008.

4. 2008 - Phase I Ascorbate Hoffer Annals Oncol 2008.pdf; Phase I clinical trial of i.v. ascorbic acid in advanced malignancy, L. J. Hoffer1*, M. Levine et al, Annals of Oncology 19: 1969–1974, SUMMARY: High-dose i.v. ascorbic acid was well tolerated

5. 2006 - http://www.cmaj.ca/content/174/7/937.long - CMAJ March 28, 2006 vol. 174 no. 7 doi: 10.1503/cmaj.050346 Intravenously administered vitamin C as cancer therapy: three cases, Sebastian J. Padayatty, MARK LEVINE, et al SUMMARY: the maximum tolerated dose of vitamin C (18 g/d) produces peak plasma concentrations of only 220 μmol/L, whereas intravenous administration of the same dose produces plasma concentrations about 25-fold higher. Larger doses (50–100 g) given intravenously may result in plasma concentrations of about 14 000 μmol/L. At concentrations above 1000 μmol/L, vitamin C is toxic to some cancer cells but not to normal cells in vitro. We found 3 well-documented cases of advanced cancers, confirmed by histopathologic review, where patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy.

6. 1994 Jan;151(1):21-6. J Urol Megadose vitamins in bladder cancer: a double-blind clinical trial. Lamm DL, Riggs DR, Shriver JS, vanGilder PF, Rach JF, DeHaven JI.
SUMMARY: The 5-year estimates of tumor recurrence are 91% in the RDA arm and 41% in the megadose arm; recommended daily allowance (RDA) versus RDA multivitamins plus 40,000 units vitamin A, 100 mg. vitamin B6, 2,000 mg. vitamin C, 400 units vitamin E and 90 mg. zinc.

*To review the disclaimer. *To ask Nutrition Investigator (Roc) a question.

"Modern science is advancing at an unprecedented rate, and the amount of scientific data is doubling every year." -Raddick et al, Science 3298:1028 (2010)